Pictet Asset Management (Switzerland)’s ResMed RMD Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$14.8M	Sell	67,900 -3,311	-5%	-$738K	0.02%	535
2023 Q1	$15.6M	Buy	71,211 +1,574	+2%	+$341K	0.02%	526
2022 Q4	$14.5M	Sell	69,637 -686	-1%	-$151K	0.02%	517
2022 Q3	$15.4M	Sell	70,323 -840	-1%	-$191K	0.02%	482
2022 Q2	$14.9M	Sell	71,163 -221	-0.3%	-$47K	0.02%	515
2022 Q1	$17.3M	Buy	71,384 +2,430	+4%	+$588K	0.02%	524
2021 Q4	$18M	Buy	68,954 +947	+1%	+$246K	0.02%	541
2021 Q3	$17.9M	Buy	+68,007	New	+$18.6M	0.02%	539

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s RMD Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its ResMed (RMD) stake by 4.6% in Q2 2023, selling an estimated $738K and leaving 67,900 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #535.

Pictet Asset Management (Switzerland) first reported a position in RMD in Q3 2021 and has held it in 8 quarters since. The position peaked at $18M in Q4 2021. 732 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

Pictet Asset Management (Switzerland) held 67,900 shares of ResMed worth $14.8M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 3,311 ResMed shares in Q2 2023, an estimated $738K.
ResMed made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #535 holding.
Pictet Asset Management (Switzerland) first reported a position in ResMed in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s ResMed position peaked at $18M in Q4 2021.
732 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.